📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher-risk myelodysplastic syndromes. (2014)

First Author: Seymour JF
Attributed to:  MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bjh.12723

PubMed Identifier: 24467613

Publication URI: http://europepmc.org/abstract/MED/24467613

Type: Journal Article/Review

Volume: 165

Parent Publication: British journal of haematology

Issue: 1

ISSN: 0007-1048